Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb 3:36:5B.4.1-5B.4.10.
doi: 10.1002/9780470151808.sc05b04s36.

Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor Cells

Megan D Hoban  1 , Zulema Romero  1 , Gregory J Cost  2 , Matthew Mendel  2 , Michael Holmes  2 , Donald B Kohn  1   3
Affiliations
Review

Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor Cells

Megan D Hoban et al. Curr Protoc Stem Cell Biol. .

Abstract

This unit describes the protocol for the delivery of reagents for targeted genome editing to CD34(+) hematopoietic stem/progenitor cells (HSPCs). Specifically, this unit focuses on the process of thawing and pre-stimulating CD34(+) HSPCs, as well as the details of their electroporation with in vitro-transcribed mRNA-encoding site-specific nucleases [in this case zinc-finger nucleases (ZFNs)]. In addition, discussed is delivery of a gene editing donor template in the form of an oligonucleotide or integrase-defective lentiviral vector (IDLV). Finally, an analysis of cell survival following treatment and downstream culture conditions are presented. While optimization steps might be needed for each specific application with respect to nuclease and donor template amount, adherence to this protocol will serve as an excellent starting point for this further work.

Keywords: electroporation; genome editing; hematopoietic stem cells; targeted nucleases.

PubMed Disclaimer

References

Literature Cited

    1. Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C.C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., Mahlaoui, N., Kiermer, V., Mittelstaedt, D., Bellesme, C., Lahlou, N., Lefrère, F., Blanche, S., Audit, M., Payen, E., Leboulch, P., l'Homme, B., Bougnères, P., Von Kalle, C., Fischer, A., Cavazzana-Calvo, M., and Aubourg, P. 2009. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science (New York, N.Y.) 326:818-823. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19892975 [Accessed March 27, 2015]. doi: 10.1126/science.1171242.
    1. Chapman, J.R., Taylor, M.R. G., and Boulton, S.J. 2012. Playing the end game: DNA double-strand break repair pathway choice. Mol. Cell 47:497-510. Available at: http://www.sciencedirect.com/science/article/pii/S1097276512006569 [Accessed July 14, 2014]. doi: 10.1016/j.molcel.2012.07.029.
    1. Choi, V.W., Asokan, A., Haberman, R.A., and Samulski, R.J. 2007. Production of recombinant adeno-associated viral vectors. Curr. Protoc. Hum. Genet Chapter 12:Unit 12.9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18428408 [Accessed October 14, 2015].
    1. Cooper, A.R., Patel, S., Senadheera, S., Plath, K., Kohn, D.B., and Hollis, R.P. 2011. Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration. J. Virol. Methods 177:1-9. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4276401&to... [Accessed March 24, 2015]. doi: 10.1016/j.jviromet.2011.06.019.
    1. Eichler, H., Beck, C., Bernard, F., Bugert, P., and Klüter, H. 2002. Use of recombinant human deoxyribonuclease (DNase) for processing of a thawed umbilical cord blood transplant in a patient with relapsed acute lymphoblastic leukemia. Ann. Hematol. 81:170-173. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11904746 [Accessed August 13, 2015]. doi: 10.1007/s00277-001-0419-2.

Publication types

LinkOut - more resources